The Next Coverage Hurdle: Pharmacogenomics as Formulary Control Tool
This article was originally published in RPM Report
Executive Summary
Managed care plans are taking baby steps toward incorporating genetic tests into the delivery of their pharmacy services. For drug sponsors, that could mean another hurdle to coverage of a new product.